Chuck Royce's AVNS Position Overview
Chuck Royce (via Royce & Associates Lp) currently holds 32,221 shares of Avanos Medical, Inc. (AVNS) worth $372,475, representing 0.00% of the portfolio. First purchased in 2025-Q3, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Chuck Royce has initiated a new position in AVNS, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Chuck Royce's Avanos Medical (AVNS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Avanos Medical (AVNS) Trades by Chuck Royce
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2025 | +32,221 | New Buy | 32,221 | $11.56 |
Chuck Royce's Avanos Medical Investment FAQs
Chuck Royce first purchased Avanos Medical, Inc. (AVNS) in Q3 2025, acquiring 32,221 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce has held Avanos Medical, Inc. (AVNS) for 1 quarters since Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce's largest addition to Avanos Medical, Inc. (AVNS) was in Q3 2025, adding 32,221 shares worth $372,475. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Chuck Royce's firm, Royce & Associates Lp, owns 32,221 shares of Avanos Medical, Inc. (AVNS), valued at approximately $372,475. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Avanos Medical, Inc. (AVNS) represents approximately 0.00% of Chuck Royce's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce's peak holding in Avanos Medical, Inc. (AVNS) was 32,221 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.